Outcome of the public request for information on the risks and benefits of the pain killer co-proxamol

risks and benefits of the pain killer co-proxamol

Date: 31st January 2005 Reference: CEM/CMO/2005/2 WITHDRAWAL OF CO-PROXAMOL PRODUCTS AND INTERIM UPDATED PRESCRIBING INFORMATION Dear Colleague, I am writing to tell you the advice of the Committee on Safety of Medicines (CSM) in the light of its recent review of the risks and benefits of co-proxamol. In summary, the efficacy of co-proxamol is poorly … Read more

Log In

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.